Concise Critical Appraisal: The Effect of Ramelteon Administration on the Duration of ICU Stay
Nishikimi et al (Crit Care Med. 2018;46:1099-1105) set out to identify the effects of ramelteon, a melatonin agonist, on ICU length of stay for critically ill patients.
How Critical Illness Affects the Brain... and Vice Versa
This is a presentation from the 47th Critical Care Congress on how critical illiness affects the brain.
Congress, Neurology, On Demand
My Patient Won't Wean. Acute Neuromuscular Respiratory Failure: Multiprofessional Neurology, Pulmonary, and Nursing Perspectives
This is a presentation from the 47th Critical Care Congress on weaning.
Congress, Neurology, Nursing, On Demand, pulmonary
Neuromuscular Blocking Agents in the ICU: Shortages, Pitfalls, and Strategies Moving Forward
This article was first published in the Fall 2020 issue of Critical Connections. The most common uses for neuromuscular blocking agents (NMBAs) in the intensive care unit (ICU) are in the treatment of acute respiratory distress syndrome (ARDS), status asthmaticus, rapid sequence intubation (RSI), and therapeutic hyperthermia.1
ARDS, Critical Connections, Neurology
Neurosciences and the Pandemic
This article was first published in the Fall 2020 issue of Critical Connections. We have much to elucidate on the neurologic manifestations associated with COVID-19.
COVID-19, Critical Connections, Neurology
SCCM Pod-VCCR8 Ketamine for Refractory Status Epilepticus
Sean P. Kane, PharmD, BCPS, speaks with Karen Berger, PharmD, BCPS, BCCCP about refractory status epilepticus.